Jaap Goudsmit

Gründer bei

Leyden Laboratories B.V.

75 Jahre

87 Beziehungen

Health Technology

Health Services

Consumer Services

Profil

Jaap Goudsmit is the founder of Leyden Laboratories BV, founded in 2020, where the title held is Chief Scientific Officer.
Current jobs include Director-Emeritus at International AIDS Vaccine Initiative, Inc., Professor at Academisch Medisch Centrum since 1989, Member at New York University, and Professor at the University of Amsterdam since 1989.
Former jobs include Chairman at AIDS Foundation Houston, Inc., Chief Scientific Officer & Member-Management Board at Crucell NV from 2010 to 2012, and Senior Vice President at Vaccine Research International Plc from 2001 to 2002.
Education includes a doctorate from the University of Amsterdam.

Aktive Positionen von Jaap Goudsmit

Unternehmen	Position	Beginn
University of Amsterdam University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01.01.1989
New York University New York University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Academisch Medisch Centrum Academisch Medisch Centrum Hospital/Nursing ManagementHealth Services Operates as a medical center and provides scientific research & education services for next generation of healthcare professionals	Corporate Officer/Principal	01.01.1989
International AIDS Vaccine Initiative, Inc. International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS	Corporate Officer/Principal	-
Leyden Laboratories B.V. Leyden Laboratories B.V. Pharmaceuticals: MajorHealth Technology Develops nasal sprays containing antibodies that target respiratory viruses	Gründer	01.01.2020

Alle aktiven Positionen von Jaap Goudsmit

Ehemalige bekannte Positionen von Jaap Goudsmit

Unternehmen	Position	Ende
Vaccine Research International Plc Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Working towards further clinical trials to examine the potential of vaccine SA75 to prevent staphylococcal infections in hospital patients and the wider community.	Corporate Officer/Principal	01.07.2002
AIDS Foundation Houston, Inc. AIDS Foundation Houston, Inc. Hospital/Nursing ManagementHealth Services Provides housing and nursing care for the sick	Vorsitzender	-
Crucell NV Crucell NV Pharmaceuticals: MajorHealth Technology Develops, produces and markets vaccines, proteins and antibodies	Technik-/Wissenschafts-/F&E-Leiter	-

Sehen Sie sich die Erfahrung von Jaap Goudsmit im Detail an

Ausbildung von Jaap Goudsmit

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jaap Goudsmit im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	8
Crucell NV Crucell NV Pharmaceuticals: MajorHealth Technology Develops, produces and markets vaccines, proteins and antibodies	Health Technology
International AIDS Vaccine Initiative, Inc. International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS	Health Technology
Academisch Medisch Centrum Academisch Medisch Centrum Hospital/Nursing ManagementHealth Services Operates as a medical center and provides scientific research & education services for next generation of healthcare professionals	Health Services
AIDS Foundation Houston, Inc. AIDS Foundation Houston, Inc. Hospital/Nursing ManagementHealth Services Provides housing and nursing care for the sick	Health Services
New York University New York University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Amsterdam University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vaccine Research International Plc Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Working towards further clinical trials to examine the potential of vaccine SA75 to prevent staphylococcal infections in hospital patients and the wider community.	Commercial Services
Leyden Laboratories B.V. Leyden Laboratories B.V. Pharmaceuticals: MajorHealth Technology Develops nasal sprays containing antibodies that target respiratory viruses	Health Technology